Plant-derived exosomal nanoparticles: potential therapeutic for inflammatory bowel disease
De-feng Li,Qi Tang,Mei-feng Yang,Hao-ming Xu,Min-zheng Zhu,Yuan Zhang,Cheng-mei Tian,Yu-Qiang Nie,Jian-yao Wang,Yujie Liang,Li-Sheng Wang,Jun Yao
DOI: https://doi.org/10.1039/d3na00093a
IF: 5.598
2023-06-30
Nanoscale Advances
Abstract:Inflammatory bowel disease (IBD), encompassing Crohn's disease and ulcerative colitis, is a chronic autoimmune disorder characterized by inflammation. However, currently available disease-modifying anti-IBD drugs exhibit limited efficacy in IBD therapy. Furthermore, existing therapeutic approaches provide only partial relief from IBD symptoms and are associated with certain side effects. In recent years, a novel category of nanoscale membrane vesicles, known as plant-derived exosome-like nanoparticles (PDENs), has been identified in edible plants. These PDENs are abundant in bioactive lipids, proteins, microRNAs, and other pharmacologically active compounds. Notably, PDENs possess immunomodulatory, antitumor, regenerative, and anti-inflammatory properties, making them particularly promising for the treatment of intestinal diseases. Moreover, PDENs can be engineered as targeted delivery systems for the efficient transport of chemical or nucleic acid drugs to the site of intestinal inflammation. In the present study, we provided an overview of PDENs, including their biogenesis, extraction, purification, and construction strategies, and elucidated their physiological functions and therapeutic effects on IBD. Additionally, we summarized the applications and potential of PDENs in IBD treatment while highlighting the future directions and challenges in the field of emerging nanotherapeutics for IBD therapy.
materials science, multidisciplinary,nanoscience & nanotechnology,chemistry